WHO - Health Systems and Services: Prequalification of Medicines Programme                                                                     :: Site Map

PREQUALIFICATION PROGRAMME
A United Nations Programme managed by WHO

Vision

Good quality medicines for everyone.

Mission

In close cooperation with national regulatory agencies and partner organizations, the Prequalification Programme aims to make quality priority medicines available for the benefit of those in need.

This is achieved through its evaluation and inspection activities, and by building national capacity for sustainable manufacturing and monitoring of quality medicines.

Strategy

  • Apply unified standards of acceptable quality, safety and efficacy.

  • Comprehensively evaluate the quality, safety and efficacy of medicinal products, based on information submitted by the manufacturers, and inspection of the corresponding manufacturing and clinical sites.

  • Prequalify quality control laboratories of pharmaceuticals.

  • Build the capacity of staff from national regulatory authorities, quality control laboratories, and from manufacturers or other private companies, to ensure medicines quality.

Key output

The list of prequalified medicinal products used for HIV/AIDS, malaria, tuberculosis and for reproductive health produced by the Programme is used principally by United Nations agencies including UNAIDS and UNICEF to guide their procurement decisions. But, the list has become a vital tool for any agency or organization involved in bulk purchasing of medicines, be this at country level, or at international level, as demonstrated by the Global Fund to Fight AIDS, Tuberculosis and Malaria.

 


New WHO Assessment Reports published - II

New WHO Assessment Report published - I

Paediatric Formulations workshop postponed. New dates and location to be posted

Sampled WHO prequalified anti-TB medicines show zero failure rate

Contaminated magnesium stearate excipient in finished products

Update: Falsified lamivudine, zidovudine and nevirapine tablets (Zidolam-N) in Kenya

ASAQ Winthrop® tablets batch recall

        All News

Contact us

Prequalified Medicines

Prequalified APIs

Prequalified QC Labs

Dossier status

Facts & Figures 2010

2010 Manufacturers' Survey

WHO initiates prequalification of APIs

Joint PQP and Patent Pool Q&A

QAMSA Report 2011

6th Consultative Stakeholder Meeting

Notice: Requirements for stability studies

WHO Public Assessment Reports: WHOPARs

WHO Public Inspection Reports: WHOPIRs

US FDA Public Assessment Reports

:: Prequalification of
    diagnostics


:: Prequalification of
    vaccines